Liver Cancer

Show only recruiting trials?

Roche.png

IMBrave | WO41535

A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation (IMbrave050)

Status

Recruiting

JCP

JCP071

NCT

NCT04102098

Roche.png

QBGJ398-301

Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions / Translocations

Status

Recruiting

JCP

JCP068

NCT

NCT03773302

Roche.png

COSMIC-312 | XL184-312

Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Subjects With Advanced HCC Who Have Not Received Previous Systemic Anticancer Therapy (COSMIC-312)

Status

Closed to Accrual

JCP

JCP062

NCT

NCT03755791

Roche.png

IMbrave150 | YO40245

A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma [IMbrave150]

Status

Closed to Accrual

JCP

JCP037

NCT

NCT03434379

Roche.png

NuTide 121

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer (NuTide:121)

Status

Closed to Accrual

JCP

JCP072

NCT

NCT04163900

Filter Clinical Trials by:

arrow&v
arrow&v
arrow&v
arrow&v

Biomarkers:

No trials match your search criteria